Welcome to our dedicated page for CEMTREX news (Ticker: $CETX), a resource for investors and traders seeking the latest updates and insights on CEMTREX stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CEMTREX's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CEMTREX's position in the market.
Cemtrex Inc. (NASDAQ: CETX, CETXP) will host a conference call on May 14, 2024, to discuss its fiscal second-quarter results. The call will be led by CEO Saagar Govil and CFO Paul Wyckoff. The results will be issued in a press release prior to the call. Interested parties can access the call through provided information. A replay will be available after the call.
Cemtrex, Inc. announced the closing of an upsized underwritten public offering, raising approximately $10 million in gross proceeds. The offering was increased from $9 million and consisted of Common Units and Pre-Funded Units. Each Common Unit was priced at $0.85, while each Pre-Funded Unit was priced at $0.849. The Company plans to use the net proceeds for operations, marketing, business initiatives, product investment, and partial debt repayment. Aegis Capital Corp. was granted a 45-day option to purchase additional Common Shares and/or Warrants.
Cemtrex, Inc. announced the pricing of an upsized underwritten public offering, expecting gross proceeds of approximately $10 million. The Company plans to use the net proceeds for operations, marketing efforts, investment in existing initiatives, partial debt repayment, and potential acquisition of complementary businesses. The offering consists of Common Units and Pre-Funded Units, with Aegis Capital Corp. as the sole book-running manager. The closing is expected on May 3, 2024.